
ALPMF
Healthcare · Drug Manufacturers - General · $31.06B market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 5, 2026 | After the close | 18.10 | 0.50 | -97.3% |
| Feb 4, 2026 | After the close | 8.07 | 0.36 | -95.5% |
| Oct 30, 2025 | After the close | 15.97 | 0.30 | -98.1% |
| Jul 30, 2025 | After the close | 10.20 | 0.26 | -97.4% |
| Apr 25, 2025 | Before the open | — | 41.84 | — |
| Feb 4, 2025 | Before the open | 23.40 | -54.55 | -333.1% |
| Oct 30, 2024 | Before the open | 22.60 | 20.06 | -11.2% |
| Aug 1, 2024 | Before the open | 13.20 | 21.00 | +59.1% |
| Apr 25, 2024 | Before the open | 3.82 | -18.55 | -585.6% |
| Feb 5, 2024 | Before the open | 17.80 | 10.40 | -41.6% |
| Nov 1, 2023 | Before the open | 29.36 | -0.81 | -102.8% |
| Aug 1, 2023 | Before the open | 31.63 | 18.46 | -41.6% |
| Apr 27, 2023 | Before the open | -4.16 | -25.49 |
Astellas Pharma Inc. engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric adenocarcinoma and esophagogastric junction adenocarcinoma; and PADCEV, a treatment for patients with metastatic urothelial carcinoma. It…
| -512.7% |
| Feb 6, 2023 | Before the open | — | 26.56 | — |
| Oct 31, 2022 | Before the open | — | 39.28 | — |
| Jul 31, 2022 | After the close | — | 13.60 | — |
| Apr 26, 2022 | After the close | — | -4.43 | — |
| Feb 1, 2022 | After the close | — | 32.86 | — |
| Oct 28, 2021 | After the close | — | 22.09 | — |
| Jul 29, 2021 | After the close | — | 16.56 | — |
| Apr 26, 2021 | After the close | — | -6.63 | — |
| Jan 28, 2021 | After the close | — | 32.35 | — |
| Oct 29, 2020 | After the close | — | 12.07 | — |
| Aug 3, 2020 | After the close | — | 27.14 | — |
| May 14, 2020 | Before the open | — | 3.19 | — |
| Jan 30, 2020 | After the close | — | 32.80 | — |
| Oct 31, 2019 | Before the open | — | 37.13 | — |
| Jul 29, 2019 | After the close | — | 31.03 | — |
| Apr 24, 2019 | After the close | — | 16.42 | — |
| Jan 30, 2019 | After the close | — | 45.43 | — |
| Oct 30, 2018 | After the close | — | 25.52 | — |
| Jul 26, 2018 | After the close | — | 27.68 | — |
| Apr 26, 2018 | Before the open | 16.58 | 11.27 | -32.0% |
| Jan 31, 2018 | Before the open | 29.60 | 29.87 | +0.9% |